Chester County News and Community Website
WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT), announced that it has received a non-binding letter of intent to sell its preclinical oncology aPKCi inhibitor platform for $7 million in …
Windtree Therapeutics Receives $7 Million Offer for Preclinical Oncology Platform Read More
NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that Aetna Healthcare has authorized a claim for reimbursement for its Portable Neuromodulation Stimulator (PoNS) Device, marking a significant milestone …
Helius Medical Secures Aetna Approval for PoNS Device Reimbursement Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced a strategic acquisition of Titan Environmental Services, Inc. (OTC: TESI), marking a significant step in its shift toward profitability and entry …
Windtree Therapeutics Acquires Titan Environmental Services to Drive Profitability Read More
SOUTHAMPTON, PA — Environmental Tectonics Corporation (OTC Pink: ETCC) has reported substantial improvements across key financial metrics for the fiscal year ending February 28, 2025. The company attributed its strong …
Environmental Tectonics Corporation Reports Significant Growth in Fiscal 2025 Results Read More NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) announced that on June 3, 2025, it received notice from the Nasdaq Hearings Panel confirming compliance with the minimum bid price …
Helius Medical Secures Nasdaq Bid Price Compliance, Eyes Equity Requirement Deadline Read More WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) has revealed plans to adopt a cryptocurrency policy, marking a significant step toward integrating digital finance into its operations. The policy will …
Windtree Therapeutics Announces Move into Cryptocurrency Payments and Holdings Read More
NEWTOWN, PA — Traws Pharma, Inc. (NASDAQ: TRAW) has unveiled key clinical efficacy data for rigosertib, showcasing its potential as a treatment for squamous cell carcinoma (SCC) associated with recessive …
Traws Pharma Announces Promising Clinical Data for Rigosertib in Rare Cancer Read More
LANGHORNE, PA — TEN Holdings, Inc. (NASDAQ: XHLD), through its subsidiary Ten Events, Inc., has announced the launch of an Early Adopter Program for its software-as-a-service (SaaS) product, Ten Events …
TEN Holdings Launches Early Adopter Program for New SaaS Platform Ten Events Pro Read More
LANGHORNE, PA — Savara Inc. (Nasdaq: SVRA) has announced receiving a Refuse-to-File (RTF) letter from the U.S. Food and Drug Administration (FDA) for its Biologics License Application (BLA) of MOLBREEVI, …
FDA Requests Additional Data for Savara’s MOLBREEVI Application Read More LANGHORNE, PA — TEN Holdings, Inc. (NASDAQ: XHLD) has revealed its upcoming participation in several high-profile investor-focused conferences and webinars in June 2025. These engagements aim to boost the company’s …
TEN Holdings to Participate in Key Investor Events Throughout June 2025 Read More